ResearcherNational Institutes for Quantum Science and TechnologyNo recent work listed
Tsuneo Saga
Matched on ORCID iD 0000-0001-7801-9316; OpenAlex author ID A5078877030. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 5
2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper
Papers 8
- Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer. Co-author DOI 10.3892/or.2019.7017↗
- Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a … Co-author DOI 10.3390/ijms19102979↗
- Combined treatment of pancreatic cancer xenograft with 90Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor. Co-author DOI 10.3748/wjg.v23.i42.7551↗
- Immunotargeting of Integrin α6β4 for Single-Photon Emission Computed Tomography and Near-Infrared Fluorescence Imaging in a Pancreatic Cancer Model. Last author DOI 10.1177/1536012115624917↗
- Radioimmunotherapy of pancreatic cancer xenografts in nude mice using 90Y-labeled anti-α6β4 integrin antibody. Last author DOI 10.18632/oncotarget.9631↗
- Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model. Last author DOI 10.1097/mnm.0000000000000245↗
- Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models. Last author DOI 10.1371/journal.pone.0123761↗
- Evaluation of (89)Zr-labeled human anti-CD147 monoclonal antibody as a positron emission tomography probe in a mouse model of pancreatic cancer. Last author DOI 10.1371/journal.pone.0061230↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aya Sugyo · 8 shared papers, 2013–2019 · strength 0.50
- Paper Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic can… DOI 10.3892/or.2019.7017↗
- Paper Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti… DOI 10.3390/ijms19102979↗
- Paper Combined treatment of pancreatic cancer xenograft with 90Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor. DOI 10.3748/wjg.v23.i42.7551↗
- Winn Aung U · 4 shared papers, 2016–2019 · strength 0.28
- Paper Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic can… DOI 10.3892/or.2019.7017↗
- Paper Combined treatment of pancreatic cancer xenograft with 90Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor. DOI 10.3748/wjg.v23.i42.7551↗
- Paper Immunotargeting of Integrin α6β4 for Single-Photon Emission Computed Tomography and Near-Infrared Fluorescence Imaging … DOI 10.1177/1536012115624917↗
- Tatsuya Higashi · 3 shared papers, 2017–2019 · strength 0.25
- Paper Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic can… DOI 10.3892/or.2019.7017↗
- Paper Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti… DOI 10.3390/ijms19102979↗
- Paper Combined treatment of pancreatic cancer xenograft with 90Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor. DOI 10.3748/wjg.v23.i42.7551↗
- Masahiro Yasunaga · 1 shared paper, 2019 · strength 0.10
- Yasuhiro Matsumura · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.